<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35060361</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Long COVID-19: Objectifying most self-reported neurological symptoms.</ArticleTitle><Pagination><StartPage>141</StartPage><EndPage>154</EndPage><MedlinePgn>141-154</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51496</ELocationID><Abstract><AbstractText Label="OBJECTIVES">We aimed to objectify and compare persisting self-reported symptoms in initially hospitalized and non-hospitalized patients after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by applying clinical standardized measures.</AbstractText><AbstractText Label="METHODS">We conducted a cross-sectional study of adult patients with confirmed SARS-CoV-2 infection including medical history, neurological examination, blood markers, neuropsychological testing, patient-reported outcome measures (PROMs), and brain magnetic resonance imaging (MRI).</AbstractText><AbstractText Label="RESULTS">Fifty patients with persisting symptoms for at least 4&#x2009;weeks were included and classified by initial hospitalization status. Median time from SARS-CoV-2 detection to investigation was 29.3&#x2009;weeks (range 3.3-57.9). Although individual cognitive performance was generally within the normative range in both groups, mostly mild deficits were found in attention, executive functions, and memory. Hospitalized patients performed worse in global cognition, logical reasoning, and processes of verbal memory. In both groups, fatigue severity was associated with reduced performance in attention and psychomotor speed tasks (r<sub>s</sub> &#x2009;=&#x2009;-0.40, p&#x2009;&lt;&#x2009;0.05) and reduced quality of life (EQ5D, r<sub>s</sub> &#x2009;=&#x2009;0.57, p&#x2009;&lt;&#x2009;0.001) and with more persisting symptoms (median 3 vs. 6, p&#x2009;&lt;&#x2009;0.01). PROMs identified fatigue, reduced sleep quality, and increased anxiety and depression in both groups but more pronounced in non-hospitalized patients. Brain MRI revealed microbleeds exclusively in hospitalized patients (n&#x2009;=&#x2009;5).</AbstractText><AbstractText Label="INTERPRETATION">Regardless of initial COVID-19 severity, an individuals' mental and physical health can be severely impaired in the long-term limitedly objectified by clinical standard diagnostic with abnormalities primarily found in hospitalized patients. This needs to be considered when planning rehabilitation therapies and should give rise to new biomarker research.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bungenberg</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JARA Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum J&#xfc;lich GmbH and RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humkamp</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hohenfeld</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JARA Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum J&#xfc;lich GmbH and RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rust</LastName><ForeName>Marcus Immanuel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department of Neurology, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ermis</LastName><ForeName>Ummehan</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Neurology, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dreher</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pneumonology and Internal Intensive Care Medicine, RWTH University Hospital, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartmann</LastName><ForeName>Niels-Ulrik Korbinian</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Angiology and Internal Intensive Care Medicine, RWTH University Hospital, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marx</LastName><ForeName>Gernot</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Operative Intensive und Intermediate Care Medicine, RWTH University Hospital, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binkofski</LastName><ForeName>Ferdinand</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Clinical Cognitive Sciences, Department of Neurology, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finke</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7665-1171</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulz</LastName><ForeName>J&#xf6;rg B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0002-8903-0593</Identifier><AffiliationInfo><Affiliation>Department of Neurology, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JARA Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum J&#xfc;lich GmbH and RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Ana Sofia</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-1999-6616</Identifier><AffiliationInfo><Affiliation>Department of Neurology, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JARA Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum J&#xfc;lich GmbH and RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reetz</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9730-9228</Identifier><AffiliationInfo><Affiliation>Department of Neurology, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JARA Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum J&#xfc;lich GmbH and RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="Y">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>There is no potential competing interest to be stated by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35060361</ArticleId><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="doi">10.1002/acn3.51496</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
COVID&#x2010;19 rapid guideline: managing the long&#x2010;term effects of COVID&#x2010;19. 18 December 2020. www.nice.org.uk/guidance/ng188. Accessed November 11, 2021.</Citation></Reference><Reference><Citation>Goertz YMJ, Van Herck M, Delbressine JM, et&#xa0;al. Persistent symptoms 3 months after a SARS&#x2010;CoV&#x2010;2 infection: the post&#x2010;COVID&#x2010;19 syndrome? ERJ Open Res. 2020;6(4):00542&#x2010;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et&#xa0;al. Attributes and predictors of Long COVID. Nat Med. 2021;27:626&#x2010;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, et&#xa0;al. 6&#x2010;month neurological and psychiatric outcomes in 236 379 survivors of COVID&#x2010;19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2010;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Szeghy RE, Province VM, Stute NL, et&#xa0;al. Carotid stiffness, intima&#x2010;media thickness and aortic augmentation index among adults with SARS&#x2010;CoV&#x2010;2. Exp Physiol. 2021. 10.1113/EP089481</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP089481</ArticleId><ArticleId IdType="pmc">PMC8239784</ArticleId><ArticleId IdType="pubmed">33904234</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, et&#xa0;al. Persistent fatigue following SARS&#x2010;CoV&#x2010;2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Lu S, Chen J, et&#xa0;al. The landscape of cognitive function in recovered COVID&#x2010;19 patients. J Psychiatr Res. 2020;129:98&#x2010;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, et&#xa0;al. Persistent neurologic symptoms and cognitive dysfunction in non&#x2010;hospitalized Covid&#x2010;19 "long haulers". Ann Clin Transl Neurol. 2021;8:1073&#x2010;1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A, Vanderlind WM, Alexopoulos GS, et&#xa0;al. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID&#x2010;19. Neuropsychopharmacology. 2021;46:2235&#x2010;2240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JH, Lin JJ, Doernberg M, et&#xa0;al. Assessment of cognitive function in patients after COVID&#x2010;19 infection. JAMA Netw Open. 2021;4(10):e2130645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, et&#xa0;al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta&#x2010;analysis with comparison to the COVID&#x2010;19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2010;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID&#x2010;19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID&#x2010;19 cases in the USA. Lancet Psychiatry. 2021;8(2):130&#x2010;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Lee MK. Neuroimaging findings of brain MRI and CT in patients with COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Eur J Radiol. 2020;133:109393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606068</ArticleId><ArticleId IdType="pubmed">33161199</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S &amp; Alfaro&#x2010;Almagro F et&#xa0;al. Brain imaging before and after COVID&#x2010;19 in UKBiobank. medRxiv [Preprint]. 2021:2021.06.11.21258690. 10.1101/2021.06.11.21258690</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.11.21258690</ArticleId></ArticleIdList></Reference><Reference><Citation>
Silva LS, Joao RB &amp; Nogueira MH et&#xa0;al. Functional and microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID&#x2010;19. medRxiv [Preprint]. 2021:2021.03.20.21253414. https://www.medrxiv.org/content/10.1101/2021.03.20.21253414v2.full.pdf+html. Accessed November 9, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253414v2.full.pdf%2Bhtml</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermis U, Rust MI, Bungenberg J, et&#xa0;al. Neurological symptoms in COVID&#x2010;19: a cross&#x2010;sectional monocentric study of hospitalized patients. Neurol Res Pract. 2021;3(1):17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953515</ArticleId><ArticleId IdType="pubmed">33712089</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, Bedirian V, et&#xa0;al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695&#x2010;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman P, Fimm B. Testbatterie zur Aufmerksamkeitspr&#xfc;fung (TAP) Version 1.7. PSYTEST; 2002.</Citation></Reference><Reference><Citation>Wagner S, Helmreich I, Dahmen N, et&#xa0;al. Reliability of three alternate forms of the Trail Making Tests a and B. Arch Clin Neuropsychol. 2011;26(4):314&#x2010;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">21576092</ArticleId></ArticleIdList></Reference><Reference><Citation>Thalmann B, Monsch AU, Schneitter M, et&#xa0;al. Die CERAD Neuropsychologische Testbatterie. Memory Clinic; 1998.</Citation></Reference><Reference><Citation>Aschenbrenner S, Tucha O, Lange K. Regensburg Word Fluency Test [RegensburgerWortfl&#xfc;ssigkeits&#x2010;Test (RWT)]. Hogrefe; 2000.</Citation></Reference><Reference><Citation>B&#xe4;umler G. Farbe&#x2010;Wort&#x2010;Interferenztest (FWIT) nach J. R. Stroop. Hogrefe; 1985.</Citation></Reference><Reference><Citation>Helmstaedter C, Lendt M, Lux S. Verbaler Lern&#x2010; und Merkf&#xe4;higkeitstest. Hogrefe; 2001.</Citation></Reference><Reference><Citation>Meyers JE, Meyers KR. Rey Complex Figure&#xa0;Test and Recognition Trial. Hogrefe; 1995.</Citation></Reference><Reference><Citation>Hummel T, Sekinger B, Wolf SR, et&#xa0;al. Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997;22(1):39&#x2010;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9056084</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann&#x2010;Lingen C, Buss U, Snaith RP. Hospital Anxiety and Depression Scale: HADS&#x2010;D &#x2010; Deutsche Version; Ein Fragebogen Zur Erfassung von Angst Und Depressivit&#xe4;t in Der Somatischen Medizin &#x2010; Testdokumentation Und Handanweisung. Huber; 2005.</Citation></Reference><Reference><Citation>Penner IK, Raselli C, Stocklin M, et&#xa0;al. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis&#x2010;related fatigue. Mult Scler. 2009;15(12):1509&#x2010;1517.</Citation><ArticleIdList><ArticleId IdType="pubmed">19995840</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse DJ, Reynolds CF, Monk TH, et&#xa0;al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193&#x2010;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540&#x2010;545.</Citation><ArticleIdList><ArticleId IdType="pubmed">1798888</ArticleId></ArticleIdList></Reference><Reference><Citation>Prosiegel M, B&#xf6;ttger S, Schenk T. Der Erweiterte Barthel&#x2010;Index (EBI) &#x2013; eine neue Skala zur Erfassung von F&#xe4;higkeitsst&#xf6;rungen bei neurologischen Patienten. Neurol Rehabil. 1996;2:7&#x2010;13.</Citation></Reference><Reference><Citation>Sander C, Hegerl U, Wirkner K, et&#xa0;al. Normative values of the Epworth Sleepiness Scale (ESS), derived from a large German sample. Sleep Breath. 2016;20(4):1337&#x2010;1345.</Citation><ArticleIdList><ArticleId IdType="pubmed">27234595</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper L, Fumagalli GG, Barkhof F, et&#xa0;al. MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post&#x2010;mortem confirmed cases. Brain. 2016;139(Pt 4):1211&#x2010;1225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4806219</ArticleId><ArticleId IdType="pubmed">26936938</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlund LO, Barkhof F, Fazekas F, et&#xa0;al. A new rating scale for age&#x2010;related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318&#x2010;1322.</Citation><ArticleIdList><ArticleId IdType="pubmed">11387493</ArticleId></ArticleIdList></Reference><Reference><Citation>Doubal FN, MacLullich AM, Ferguson KJ, et&#xa0;al. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450&#x2010;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">20056930</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham H, de Gruijter NM, Raine C, et&#xa0;al. Male sex identified by global COVID&#x2010;19 meta&#x2010;analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11(1):6317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726563</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, et&#xa0;al. Neurological associations of COVID&#x2010;19. Lancet Neurol. 2020;19(9):767&#x2010;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, et&#xa0;al. Neurological and neuropsychiatric complications of COVID&#x2010;19 in 153 patients: a UK&#x2010;wide surveillance study. Lancet Psychiatry. 2020;7(10):875&#x2010;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et&#xa0;al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud M, Thibault C, Le Normand F, et&#xa0;al. Clinical outcomes for patients with anosmia 1 year after COVID&#x2010;19 diagnosis. JAMA Netw Open. 2021;4(6):e2115352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226421</ArticleId><ArticleId IdType="pubmed">34165581</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R, Conte C, Lanzani C, et&#xa0;al. Residual clinical damage after COVID&#x2010;19: a retrospective and prospective observational cohort study. PLoS One. 2020;15(10):e0239570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556454</ArticleId><ArticleId IdType="pubmed">33052920</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, et&#xa0;al. Anxiety and depression in COVID&#x2010;19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2010;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovitz B, Jaywant A, Fridman CB. Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: implications for the current COVID&#x2010;19 pandemic. Clin Neuropsychol. 2020;34(7&#x2013;8):1453&#x2010;1479.</Citation><ArticleIdList><ArticleId IdType="pubmed">32901580</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeria M, Cejudo JC, Sotoca J, et&#xa0;al. Cognitive profile following COVID&#x2010;19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020;9:100163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7581383</ArticleId><ArticleId IdType="pubmed">33111132</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, et&#xa0;al. Cognitive deficits in people who have recovered from COVID&#x2010;19. EClinicalMedicine. 2021;39:101044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, et&#xa0;al. Cerebral micro&#x2010;structural changes in COVID&#x2010;19 patients &#x2010; an MRI&#x2010;based 3&#x2010;month follow&#x2010;up study. EClinicalMedicine. 2020;25:100484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>